Clinical Trial Update: Study of Desvenlafaxine in Treating Major Depressive Disorder. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating desvenlafaxine for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED